German researchers said FDG PET/CT helped them differentiate between the patients with congestive heart failure who were responders and nonresponders to cardiac resynchronization therapy. The researchers later this year plan to undertake a trial that will assess patients before therapy to pinpoint those who likely would benefit from implantation, as well as develop a treatment management plan.

Related Summaries